San Diego, CA (PRWEB) April 17, 2013
Resource4thePeople announced today that its attorneys are offering free legal consultations to patients who used a certain type of diabetes drug including Byetta and allegedly suffered severe side effects of the pancreas.
The consultations are being offered in response to a large volume of inquiries from consumers over the Food and Drug Administration’s announcement* that it is investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs such as Byetta for type 2 diabetes.
An FDA spokesman said that the findings were based on examination of a small number of pancreatic tissue specimens taken from patients after they died from unspecified causes.
The FDA has asked the researchers to provide the methodology used to collect and study these specimens and to provide the tissue samples so the agency can further investigate potential pancreatic toxicity associated with the incretin mimetics.
The FDA identified these drugs as exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto).
“There are a significant number of Americans who treat their diabetes with these medications and the FDA announcement generated a large number of inquiries from patients who have asked about their legal options in cases in which they allegedly suffered these serious side effects,” said Resource4thePeople.
“As a result, out national legal network is now offering free legal consultations in which consumers may determine their eligibility to file a claim or lawsuit and see
Copyright©2012 Vocus, Inc.
All rights reserved